Contribution of endothelial progenitor cells to neovascularization (review)

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1000-1006

  Li, Da Wei ^a   Liu, Zhi Qiang ^a   Wei, Jun ^a,b   Liu, Ying ^a   Hu, Lin Sen ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Yichang Central People's Hospital   (China)

Author keywords

Cytokines; Endothelial progenitor cells; Neovascularization

Indexed keywords

ACTIN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; COFILIN; GELATINASE B; INTERLEUKIN 8; NITRIC OXIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ACTIN FILAMENT; ANGIOGENESIS; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BONE MARROW; CELL ADHESION; CELL MIGRATION; CELL POPULATION; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HYPEROXIA; MONONUCLEAR CELL; NEOINTIMA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STROMA CELL; WOUND HEALING;

ANIMALS; BLOOD VESSELS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 84866628466     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1108     Document Type: Review

References (97)

1. Asahara T, Murohara T, Sulli van A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
2. Rehman J, Li J, Orschell CM and March KL: Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
3. Yoder MC, Mead LE, Prater D, et al: Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/ progenitor cell principals. Blood 109: 1801-1809, 2007.
4. Hur J, Yoon CH, Kim HS, et al: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293, 2004.
5. Hill JM, Zalos G, Halcox JPJ, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
6. Ito H, Rovira II, Bloom ML, et al: Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 59: 5875-5877, 1999.
7. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
8. Gunsilius E, Duba HC, Petzer AL, et al: Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355: 1688-1691, 2000.
9. Yoon CH, Hur J, Park KW, et al: Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112: 1618-1627, 2005.
10. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
11. Dimmeler S, Aicher A, Vasa M, et al: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
12. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al: Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760, 2004.
13. Lin Y, Weisdorf DJ, Solovey A and Hebbel RP: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
14. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A and Yoder MC: Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: 2783-2786, 2005.
15. Melero-Martin JM, Khan ZA, Picard A, et al: In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109: 4761-4768, 2007.
16. Lapidot T and Petit I: Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30: 973-981, 2002.
17. Lapidot T, Dar A and Kollet O: How do stem cells find their way home? Blood 106: 1901-1910, 2005.
18. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
19. Yoshida A, Anand-Apte B and Zetter BR: Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13: 57-64, 1996.
20. Brkovic A and Sirois MG: Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. J Cell Biochem 100: 727-737, 2007.
21. Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543, 1999.
22. Gavard J and Gutkind JS: VEGF controls endothelial cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234, 2006.
23. Asahara T, Takahashi T, Masuda H, et al: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
24. Kalka C, Masuda H, Takahashi T, et al: Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202, 2000.
25. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H and Rafii S: Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88: 167-174, 2001.
26. Bautz F, Rafii S, Kanz L and Mohle R: Expression and secretion of vascular endothelial growth factor-A by cytokine stimulated hematopoietic progenitor cells: possible role in the hematopoietic microenvironment. Exp Hematol 28: 700-706, 2000.
27. Powell TM, Paul JD, Hill JM, et al: Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25: 296-301, 2005.
28. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637, 2002.
29. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864, 2004.
30. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC and Pesce M: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482, 2004.
31. Hattori K, Heissig B, Tashiro K, et al: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97: 3354-3360, 2001.
32. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana- Seisdesdos F, et al: Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151, 2005.
33. Asahara T and Isner JM: Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 11: 171-178, 2002.
34. + stem cell recruitment to the liver. J Clin Invest 112: 160-169, 2003.
35. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al: Effect of stromal-cell-derived factor 1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003.
36. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schonberger T, Pfisterer I, et al: Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 98: e2-e10, 2006.
37. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM and Dimmeler S: Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742, 2005.
38. Chen J and Lopez JA: Interactions of platelets with subendothelium and endothelium. Microcirculation 12: 235-246, 2005.
39. Ruggeri ZM: Mechanisms initiating platelet thrombus formation. Thromb Haemost 78: 611-616, 1997.
40. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, et al: A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197: 41-49, 2003.
41. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, et al: Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112: 1180-1188, 2005.
42. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, et al: Platelets secrete stromal cell-derived factor1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203: 1221-1233, 2006.
43. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, et al: Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461, 2004.
44. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM and Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003.
45. Laterveer L, Lindley IJ, Hamilton MS, Willemze R and Fibbe WE: Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long term myelolymphoid repopulating ability. Blood 85: 2269-2275, 1995.
46. Laterveer L, Zijlemans JM, Lindley IJ, Hamilton MS, Willemze R and Fibbe WE: Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol 24: 1387-1393, 1996.
47. Palmer RM, Ferrige AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
48. Ware JA and Heistad DD: Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. N Engl J Med 328: 628-635, 1993.
49. Goldstein LJ, Gallagher KA, Bauer SM, Bauer RJ, Baireddy V, Liu ZJ, Buerk DG, Thom SR and Velazquez OC: Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24: 2309-2318, 2006.
50. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH and Buerk DG: Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 290: H1378-H1386, 2006.
51. Griffith OW and Stuehr DJ: Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57: 707-736, 1995.
52. Marletta MA, Hurshman AR and Rusche KM: Catalysis by nitric oxide synthase. Curr Opin Chem Biol 2: 656-663, 1998.
53. Lacza Z, Puskar M, Figueroa JP, Zhang J, Rajapakse N and Busija DW: Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic Biol Med 31: 1609-1615, 2001.
54. Gallagher KA, Liu ZL, Xiao M, Chen H, et al: Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J Clin Invest 117: 1249-1259, 2007.
55. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E and Stadel JM: Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273: 4282-4287, 1998.
56. Bhakta S, Hong P and Koc O: The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 7: 19-24, 2006.
57. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J and Ratajczak MZ: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894, 2005.
58. Lapidot T: Mechanism of human stem cell migration and repopulation of NOD/SCID and B2m Null NOD/SCID mouse: the role of SDF-1/CXCR4 interactions. Ann NY Acad Sci 938: 83-95, 2001.
59. Zheng H, Fu G, Dai T and Huang H: Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/ CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274-280, 2007.
60. Akira S, Taga T and Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 54: 1-78,1993.
61. Hibi M, Nakajima K and Hirano T: IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74: 1-12, 1996.
62. Kamimura D, Ishihara K and Hirano T: Transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149: 1-38, 2003.
63. Nilsson MB, Langley RR and Fidler IJ: Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65: 10794-10800, 2005.
64. Wang Z and Newman WH: Smooth muscle cell migration stimulated by interleukin-6 is associated with cytoskeletal reorganization. J Surg Res 111: 261-266, 2003.
65. Yao JS, Zhai W, Young WL and Yang GY: Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 342: 1396-1404, 2006.
66. Fan Y, Ye Y, Shen F, et al: Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 28: 90-98, 2008.
67. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB and Caldwell RB: VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17: 1562-1564, 2003.
68. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG and Hunt JD: Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 277: 21237-21245, 2002.
69. Schraufstatter IU, Chung J and Burger M: IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280: L1094-L1103, 2001.
70. Heiss C, Wong ML, Block WI, Lao D, Real MW, Yeghiazarians Y, Lee RL and Springer ML: Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol 215: 366-373, 2008.
71. Pollard TD and Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003.
72. Revenu C, Athman R, Robine S and Louvard D: The coworkers of actin filaments: from cell structures to signals. Nat Rev Mol Cell Biol 5: 635-646, 2004.
73. Wei J, Liu Y, Chang M, Sun CL, Li DW, Liu ZQ and Hu LS: Proteomic analysis of oxidative modification in endothelial colony-forming cells treated by hydrogen peroxide. Int J Mol Med 29: 1099-1105, 2012.
74. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U and Nickenig G: Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22: 1567-1572, 2002.
75. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y and Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409, 2002.
76. Simper D, Stalboerger PG, Panetta CL, Wang S and Caplice NM: Smooth muscle progenitor cells in human blood. Circulation 106: 1199-1204, 2002.
77. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P and Mitchell RN: Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7: 738-741, 2001.
78. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS and Giordano FJ: Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110: 3300-3305, 2004.
79. Schober A, Knarren S, Lietz M, Lin EA and Weber C: Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E deficient mice. Circulation 108: 2491-2497, 2003.
80. Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Mopps B, Mericskay M, Gierschik P, Biessen EA and Weber C: SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 96: 784-791, 2005.
81. Chavakis E, Aicher A, Heeschen C, et al: Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201: 63-72, 2005.
82. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, et al: High mobility group box1 activates integrin dependent homing of endothelial progenitor cells. Circ Res 100: 204-212, 2007.
83. + blood cells. Thromb Haemost 94: 1270-1279, 2005.
84. Bombeli T, Schwartz BR and Harlan JM: Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187: 329-339, 1998.
85. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M and Varner J: A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 116: 652-662, 2006.
86. Qin G, Ii M, Silver M, Wecker A, Bord E, Ma H, et al: Functional disruption of alpha4 integrin mobilizes bone marrow derived endothelial progenitors and augments ischemic neovascularization. J Exp Med 203: 153-163, 2006.
87. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM and Asahara T: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001.
88. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM and Dimmeler S: Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516, 2003.
89. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, et al: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468, 2003.
90. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K and Imaizumi T: Transplanted cord blood derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536, 2000.
91. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, et al: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435, 2002.
92. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, Grünwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S and Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002.
93. Kovacic JC, Moore J, Herbert A, Ma D, Boehm M and Graham RM: Endothelial progenitor cells, angioblasts, and angiogenesis: old terms reconsidered from a current perspective. Trends Cardiovasc Med 18: 45-51, 2008.
94. Hirschi KK, Ingram DA and Yoder MC: Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1584-1595, 2008.
95. Murry CE, Soonpaa MH, Reinecke H, et al: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668, 2004.
96. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL and Robbins RC: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673, 2004.
97. Kamoshita E, Ikeda Y, Fujita M, Amano H, Oikawa A, et al: Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 169: 1458-1472, 2006.